Recent Articles from GlobeNewswire

First participant dosed in QUELL-DME, a Phase 2 trial of BGE-102, a potential best-in-class oral NLRP3 inhibitor, in diabetic macular edema; topline results anticipated in the second half of 2027

ROCKVILLE, Md., Nov. 05, 2026 (GLOBE NEWSWIRE) -- X-Energy, Inc. (Nasdaq: XE) (“X-energy” or “the Company”), a leading developer of advanced nuclear reactors and fuel technology today announced the selection of Fluor Corporation (“Fluor”) for design and engineering services to support Energy Northwest’s Cascade Advanced Energy Facility, a proposed Xe-100 advanced small modular reactor (“SMR”) facility near Richland, Washington. The selection builds on Fluor's work on X-energy's first proposed Xe-100 project in Texas, enabling best practices and learnings to carry into a second-of-a-kind project, supporting accelerated long-term standardized project execution.

BOISE, Idaho, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced that Linnie M. Haynesworth has informed the Company that she will retire from its board of directors at the annual shareholders meeting expected to be held on January 14, 2027.

IRVINE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to attend the following upcoming investor conferences:

Expanded expo hall, record attendance and global participation mark a milestone year for the supplement, food and beverage ecosystem

NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Mercer International Inc. (Nasdaq: MERC) today reported third quarter 2026 Operating EBITDA of negative $2.9 million, an improvement from negative $28.1 million in the same quarter of 2025 and negative $21.0 million in the second quarter of 2026.

NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) --

Net Sales of $202.1 million, up 32.5% SequentiallyRaises Second Half 2026 Net Sales OutlookNet Income of $29.9 million; Record Operating Income of $40.9 millionGross Margin Expands 580 Basis Points to 29.7%Diluted EPS of $1.30 for the QuarterTotal Debt Reduced by Approximately $34.9 million During the Quarter

CHICAGO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- TransUnion (NYSE: TRU) announced today that David Gilbert has been appointed Interim Chief Financial Officer, effective January 1, 2027, as part of a planned leadership transition from current CFO Todd Cello. Cello will remain CFO through December 31, 2026, and will then serve as a full-time advisor through March 1, 2027.

BELLINGHAM, Wash., Nov. 05, 2026 (GLOBE NEWSWIRE) -- AGNT, Inc. (Nasdaq: AGNT), formerly eXp World Holdings, Inc., (the “Company,” “AGNT” or “we”), the holding company for eXp Realty®, NextHome, Inc., FrameVR.io and SUCCESS® Enterprises, today announced financial results for the third quarter ended September 30, 2026.

Dallas, Texas, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $30.2 million, or $1.06 per share, in the third quarter of 2026 compared to a net loss of $22.2 million, or $.78 per share, in the third quarter of 2025. For the first nine months of 2026, Valhi reported net income attributable to Valhi stockholders of $54.5 million, or $1.91 per share, compared to a net loss of $4.4 million, or $.15 per share, in the first nine months of 2025. Net income attributable to Valhi stockholders increased in the third quarter of 2026 as compared to the same period of 2025 primarily due to higher operating income from our Chemicals Segment partially offset by lower operating income from our Real Estate Management and Development Segment. Net income attributable to Valhi stockholders increased in the first nine months of 2026 as compared to the same period of 2025 primarily due to higher operating income from our Chemicals Segment.

MIAMISBURG, Ohio, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Accelevation Holdings Corp. (NASDAQ: ACCV) ("Accelevation"), a leading designer, manufacturer, and installer of customized structural, electrical, and mechanical systems for mission-critical infrastructure, today announced that it will report third-quarter 2026 financial results after market close on Thursday, November 12, 2026. Management will host a conference call at 8:30 a.m. ET on Friday, November 13, 2026, to discuss the results.

MIAMI, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Laureate Education, Inc. (NASDAQ: LAUR) announced that on November 5, 2026, Universidad Peruana de Ciencias Aplicadas (UPC), a Laureate subsidiary in Peru, acquired all of the capital stock of Universidad de Ciencias y Artes de América Latina (UCAL), a Peruvian higher education institution, for a purchase price of approximately $35 million, which includes campus real estate valued at approximately $25 million. UCAL will become part of UPC upon completion of an integration process.

CINCINNATI, Nov. 05, 2026 (GLOBE NEWSWIRE) -- The E.W. Scripps Company (NASDAQ: SSP) delivered $545 million in revenue for the third quarter of 2026. Income attributable to the shareholders of Scripps was $20.7 million or 21 cents per share.

Dallas, Texas, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Kronos Worldwide, Inc. (NYSE:KRO) today reported net income of $34.8 million, or $.30 per share, in the third quarter of 2026 compared to a net loss of $37.0 million, or $.32 per share, in the third quarter of 2025. For the first nine months of 2026, Kronos reported net income of $45.2 million, or $.39 per share, compared to a net loss of $28.1 million, or $.24 per share, in the first nine months of 2025. Net income increased in the third quarter and first nine months of 2026 compared to the same periods in 2025 primarily due to higher income from operations as a result of the effects of higher sales and production volumes, lower raw material costs (primarily feedstock costs) and lower production costs resulting from cost reduction initiatives implemented in the fourth quarter of 2025, partially offset by higher distribution costs. Additionally, average TiO2 selling prices for the third quarter of 2026 were higher than the prior-year period. Our results of operations in the third quarter and first nine months of 2025 were significantly impacted by reduced demand in all major markets and unabsorbed fixed production costs due to reduced production volumes. Comparability of our results was also impacted by the effects of changes in currency exchange rates.

Dallas, Texas, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE:  VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on December 17, 2026 to stockholders of record at the close of business on November 19, 2026.

Dallas, Texas, Nov. 05, 2026 (GLOBE NEWSWIRE) -- NLI Holdings, Inc. (NYSE: NL) reported net income attributable to NLI stockholders of $12.7 million, or $.26 per share, in the third quarter of 2026 compared to a net loss of $7.8 million, or $.16 per share, in the third quarter of 2025. NLI’s results include an unrealized gain of $.9 million in the third quarter of 2026 related to the change in value of marketable equity securities compared to an unrealized loss of $.5 million in the third quarter of 2025. For the first nine months of 2026, NLI reported net income attributable to NLI stockholders of $26.0 million, or $.53 per share, compared to a net loss of $6.8 million, or $.14 per share for the first nine months of 2025. NLI results include an unrealized gain of $4.0 million in the first nine months of 2026 related to the change in value of marketable equity securities compared to an unrealized loss of $9.1 million in the first nine months of 2025. 

Harminder Sehmi to Remain with Company Through November

NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- FTAI Infrastructure Inc. (NASDAQ:FIP) (the “Company” or “FTAI Infrastructure”) today reported financial results for the third quarter 2026. The Company’s consolidated comparative financial statements and key performance measures are attached as an exhibit to this press release.

LITTLE ROCK, Ark., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its Chief Financial Officer & Treasurer, Paul Bullington, is scheduled to participate as part of a panel at the J.P. Morgan 2026 U.S. Opportunities Forum on November 12, 2026 in Miami, FL.

Simplification Strategy Drives Improved Profitability 

HAMILTON, Bermuda, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Enstar Group Limited (“Enstar”) today announced that it will pay cash dividends on its Series D and Series E preference shares.

DENVER, CO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Rank One Computing Corporation d/b/a ROC (Nasdaq: ROC) (“ROC” or the “Company”), a U.S. leader in Vision AI, building unified biometric, video analytics, and digital evidence solutions, today announced that it will release its financial results for the third quarter ended September 30, 2026, after the market close on Thursday, November 12, 2026.

Steady revenue growth and adjusted EBITDA margin* expansion

~ Files Definitive Proxy Statement/Prospectus as Combination Moves Toward Shareholder Vote ~

Launched PWRX, the first new ETF on the Texas Stock ExchangeOur ETF platform surpassed $430 million in assetsClosed $30 million in private capital commitments and nearly $200 million year-to-dateDefined contribution plan funded with over $450 million in SMidCap

— Continued Strengthening of Pipeline and Solid Topline Growth —

Q3 2026 revenue of $32.9 million; GAAP basic EPS: $(0.04)

CERRITOS, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended September 30, 2026 and updated it's full-year 2026 guidance.

The American Society of Hematology, in Partnership with D S Simon Media, Conducts Nationwide Media Tour Highlighting New Guidelines to Help Identify More People with Iron Deficiency.

LOS ANGELES, Nov. 05, 2026 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL), today announced financial results for the third quarter ended September 30, 2026.

45% Revenue Increase and 44% Growth in U.S. Procedure Volume Year-to-date

Third Quarter 2026 Highlights

Q1'27 Financial Results 

SAN CLEMENTE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2026.

MediWound Announces Closing of $17.25 Million Bought Deal Offering of Ordinary Shares

DOYLESTOWN, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers, today announced that Oren Gilad, Ph.D., President and Chief Executive Officer, will participate in a fireside chat and meet with investors at Guggenheim’s 3rd Annual Healthcare Innovation Conference, to be held November 9-11, 2026 in Boston, MA.

REGULATED INFORMATION

Third quarter SaaS revenue of $105.5 million, representing 26% year-over-year growth, 26% on a constant currency basisThird quarter Total revenue of $131.1 million, representing 19% year-over-year growth, 20% on a constant currency basisTotal ARR of $495.1 million, representing 27% year-over-year growth, 25% adjusted for FX

SCHAUMBURG, Ill., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Paylocity Holding Corporation (Nasdaq: PCTY), a leading provider of cloud-based HCM, Finance, and IT solutions, today announced financial results for the first quarter of fiscal 2027, which ended September 30, 2026.

- Consolidated Revenues Rose 4.9% Over the Prior-year Period, With Increases at American Place, Chamonix/Bronco Billy’s and Rising Star

GOLETA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, today announced that it will participate in the 2026 Stifel Deep Tech Summit on Monday, December 7, 2026. The event will be held in-person at the Rosewood Sand Hill Hotel in Menlo Park, CA. CEO Jonathan Klamkin, Ph.D., and CFO Christopher Stewart will be available for one-on-one meetings.

Reaffirms 2026 Outlook and Provides Preliminary 2027 Outlook

NEEDHAM, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced that on November 3, 2026, the Compensation Committee of Candel’s Board of Directors granted Maria Ostrovsky, in connection with her employment as Candel’s General Counsel, stock options to purchase an aggregate of 315,000 shares of the Company’s common stock, with a per share exercise price of $8.82, which is equal to the closing price of the Company’s common stock on The Nasdaq Global Market on November 3, 2026.

MOUNTAIN VIEW, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Kodiak AI, Inc. (Nasdaq: KDK), a leading provider of Physical AI-powered autonomous vehicle technology, today announced results for the third quarter ended September 30, 2026.

Third Quarter Revenue Within Guidance Range; Profit Surpasses Expectations

Proteus™ remains on track for anticipated Q2 2027 commercial launch

LONG BEACH, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial®, today announced financial results for the third quarter ended September 30, 2026 (“Q3 2026”).

Delivered Total and Net Investment Income of $40.6 million and $15.9 million, Respectively

HAMILTON, Bermuda, Nov. 05, 2026 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE:SPNT), a global specialty underwriter, today announced results for its third quarter ended September 30, 2026, and entered into a loss portfolio transfer (LPT) agreement to close the chapter on its legacy portfolio.

Delivers Strong Q3 With 53% Year-Over-Year Revenue Growth Raises Full Year 2026 Revenue Guidance

Q3'26 revenue grew 12% YoY to $258 million, at the high end of our guidance range

REDWOOD CITY, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (Rezolute or the Company), a late-stage ultra-rare, metabolic disease company focused on treating refractory hypoglycemia caused by any form of hyperinsulinism (HI), today reported financial results and provided a business update for the first quarter ended September 30, 2026.

SAN FRANCISCO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended September 30, 2026.

Underlying Business Momentum Drives Strong Third Quarter PerformanceAnnounces New $30 Million Share Repurchase AuthorizationRaises Full Year 2026 Financial Outlook

WASHINGTON, Nov. 05, 2026 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”) (Nasdaq: IBEX), a global leader in outsourced business services and AI-powered customer experience solutions, today announced financial results for its first fiscal quarter ended September 30, 2026.

WEST PALM BEACH, Fla., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Sunrise Realty Trust, Inc. (Nasdaq: SUNS) (“SUNS” or the “Company”) and Southern Realty Trust Inc. (“SRT”), two commercial real estate lenders on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced the completion of the previously announced merger of SRT with and into a wholly owned subsidiary of SUNS (the “Merger”). The Merger consolidates the two companies’ co-investments into a single, larger Nasdaq-listed commercial real estate lending platform. On a pro forma basis as of June 30, 2026, the combined company had approximately $285 million of book value (after transaction-cost adjustments), approximately $534 million of total assets and approximately $604 million of total loan commitments across 14 portfolio loans collateralized by assets located predominantly in core Southern U.S. markets. The combined company will continue to operate as Sunrise Realty Trust, Inc., and its common stock will continue to trade on Nasdaq under the ticker symbol “SUNS.”

DEER PARK, Ill., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the quarter ended September 30, 2026.

Revenue increased 12% year-over-year; homes purchased more than quadrupled; TTM marketing efficiency improved 57% and operations efficiency improved 36%.

Gross margin reaches 78%; cash used in operating activities declines 56% sequentially

Results build on preliminary Week 4 findings, in which a single dose of ATTO-1310 demonstrated rapid, deep, and durable itch relief in patients with chronic pruritus (CP) and high-itch atopic dermatitis (AD)

Received authorization in the United Kingdom and European Union to expand global first-in-human ASCEND Phase 1/2 clinical trial of CMP-002 in patients with SYNGAP1-related disorder, adding to clearances in Australia and Argentina 

DENVER, Nov. 05, 2026 (GLOBE NEWSWIRE) -- EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ: EVCM), is a leading provider of integrated, vertically-tailored software-as-a-service solutions or services that help service-based small and medium-sized businesses run smarter and grow faster, today announced financial results for the quarter ended September 30, 2026.

ROCKVILLE, MD, Nov. 05, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company’s management team will participate in the following investor conferences in November:

Advancing a pipeline built entirely on the Alector Brain Carrier (ABC) blood-brain barrier platform, spanning antibody, enzyme, and siRNA programs, with AL137, Alector's lead ABC-enabled anti-amyloid beta (Aβ) antibody program for Alzheimer's disease (AD), targeting first-in-human dosing in Australia no later than April 2027.

Continued progress toward starting SC451 Phase 1/2 trial in type 1 diabetes

SOUTH SAN FRANCISCO, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced positive data from five presentations at the American Association for the Study of Liver Disease’s (AASLD) The Liver Meeting® 2026, being held November 5 – 9, 2026 in Denver, CO.

Key Q3 2026 Highlights (from Continuing Operations)

SAN JOSE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a hybrid cloud leader and AI platform company, today announced that it will report its financial results for the first quarter of fiscal year 2027, which ended October 31, 2026, after U.S. markets close on Tuesday, November 24, 2026.

Board of Directors Declared Total Dividends of $0.54 per Share for Fourth Quarter 2026 Base Dividend of $0.43 and Supplemental Dividend of $0.11 Per Share

Delivers revenue growth of 73% in the third quarter and raises full year 2026 revenue guidance

CAMPBELL, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, today announced financial results for the third quarter ended September 30, 2026 and provided estimated fourth quarter and updated full year 2026 guidance.

CAMBRIDGE, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed” or the “Company”), a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases, today announced that on November 2, 2026, the compensation committee of Apnimed’s board of directors granted 14 new non-executive employees non-qualified stock options to purchase an aggregate of 331,000 shares of the Company’s common stock under Apnimed’s 2026 Inducement Plan (the “Plan”). Each stock option granted has an exercise price per share of $15.40, which is equal to Apnimed’s closing trading price on the grant date. One fourth of the shares underlying each of the employee’s stock options will vest on the first anniversary of each employee’s start date and in equal monthly installments thereafter for the next three years, subject to such employee’s continued employment with the Company on such vesting dates.

BERKELEY, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU) today reported financial results for the third quarter of 2026.